Could a Cancer Drug Curb the Organ Damage of Severe COVID?
MONDAY, July 8, 2024 (HealthDay News) — An experimental cancer drug might be able to help prevent the organ damage caused by severe COVID infections, a new study finds. The drug, called eganelisib, inhibits an immune system enzyme called PI3K gamma that boosts damaging inflammation in cancerous tumors. But labContinue Reading










